Nov 7 (Reuters)-
Kyorin Pharmaceutical Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2025 Sep 30, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 58.73 55.14 127.00
(+6.5 pct) (+0.4 pct) (-2.4 pct)
Operating 1.36 1.55 6.10
(-12.0 pct) (+16.0 pct) (-51.5 pct)
Recurring 1.58 2.05 6.30
(-22.8 pct) (+29.9 pct) (-52.3 pct)
Net 1.49 1.26 4.80
(+19.0 pct) (-33.6 pct) (-47.2 pct)
EPS 26.01 yen 21.86 yen 83.55 yen
Ann Div 57.00 yen 57.00 yen
-Q2 div 20.00 yen 20.00 yen
-Q4 div 37.00 yen 37.00 yen
NOTE - Kyorin Pharmaceutical Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T